Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
EPS for Genocea Biosciences (GNCA)
EPS in 2022 (TTM): -$0.52
According to Genocea Biosciences 's latest financial reports the company's current EPS (TTM) is -$0.52. In 2021 the company made an earnings per share (EPS) of -$0.48 an increase over its 2020 EPS that were of -$1.16.
EPS history for Genocea Biosciences from 2014 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$0.52 | 8.33% |
| 2021 | -$0.48 | -58.62% |
| 2020 | -$1.16 | -48.21% |
| 2019 | -$2.24 | |
| 2017 | -$15.84 | 13.14% |
| 2016 | -$14.00 | -3.31% |
| 2015 | -$14.48 | -23.31% |
| 2014 | -$18.88 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -457.69% | 🇺🇸 USA |
 Merck MRK | $1.82 | -450.32% | 🇺🇸 USA |
 Novavax NVAX | -$7.19 | 1,282.69% | 🇺🇸 USA |
 Agenus
AGEN | -$0.85 | 63.46% | 🇺🇸 USA |
 iBio IBIO | -$7.97 | 1,433.49% | 🇺🇸 USA |